NowDX News

NOWDiagnostics Honored as Finalist in the 2017 Medical Design Excellence Awards

SPRINGDALE, Ark.–(BUSINESS WIRE)–NOWDiagnostics Inc. announced that its ADEXUSDx® product line has been selected as a finalist in the “Testing and Diagnostic...

AdexusDx Platform Uses As Little As One Drop of Blood to Diagnose An Infectious Disease

Diagnosing Global Infectious Disease

What is An Infectious Disease? According to the World Health Organization (WHO), an infectious disease spreads from one person to another either directly...

The Secret Ingredient…Curiosity

Merk KGaA is a pioneer in looking at the impact curiosity can have on innovation.  Their website states, “At Merck KGaA, Darmstadt,...

360Dx on NOWDiagnostics | Zalgen Labs Collaboration

This article was originally published in 360Dx  on Mar 16, 2017 by Madeleine Johnson: “NEW YORK (360Dx) – Zalgen Labs has...

Why Are Some Diseases Neglected?

There is an entire category of diseases called “Neglected Tropical Diseases.”  Why are they called neglected?  Some say they don’t get...

Startups to Watch in 2017 – NOWDiagnostics Makes the Short List

Gaining Traction: Five startup industries to watch in 2017 The folks at NWA Business Journal | Talk Business & Politics are...

The Last Show: Closing 2016 with a Bang in the Windy City

Our last trade show of the year wrapped up this week in Chicago. RSNA is one of the largest shows, with...

FDA Completes Transfer of Emergency Use Authorization for ReEBOV® Ebola Antigen Rapid Test to Zalgen Labs

Our partners at Zalgen recently received the exciting news that the FDA has completed the transfer of Emergency Use Authorization for...

The instant food-allergy and disease test is coming to stores by “Circa”

We were pleased to have Circa reporter Daniel Bean to our facility last month.  We gave him a tour of the...

Using the A

Global Biodefense on ADEXUSDx Ebola, Tropical Diseases Tests

Published on November 3, 2016 by Global Biodefense:  News on Pathogens and Preparadness “Zalgen Labs recently announced that it has entered...